FH - hereditary leiomyomatosis and renal cell cancer
This test is available for the following conditions:
- Conditions > Renal / Nephrological > Leiomymatosis + kidney cancer
- Conditions > Oncogenetics > Leiomymatosis + kidney cancer
This product is also part of the following panels:
- panel hereditary renalcancer (SDHA, SDHB, SDHC, SDHD, SDHAF2, VHL, PTEN, FLCN, MET, FH, BAP1)
- WES comprehensive preconception carrier test ¹
- WES hereditary cancer (100.0% *)
- WES intellectual disability (100.0% *)
- WES liver disorders (100.0% *)
- WES Mendelian inherited disorders (100.0% *)
- WES metabolic disorders (100.0% *)
- WES mitochondrial disorders (100.0% *)
- WES skin disorders¹ (100.0% *)
* % of the coding region of this gene has a coverage of >20x. (Without % information : This is a non-coding gene for which coverage statistics could not be determined)
Turnaround time
Complete analysis & Targeted analysis: 3 weeks
Method
- Sequence analysis of all coding exons and flanking intron-exon boundaries
- Deletion/duplication analysis (MLPA)
OMIM:
136850
Performing laboratory: Radboudumc
Authorized material(s): EDTA blood, FFPE, Isolated DNA